Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ABX and cisplatin in advanced triple-negative breast cancer
NCT02546934Phase 3Completed
- Sponsor
- Fudan University
- Start
- Mar 2016
- Primary completion
- Apr 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of paclitaxel in triple-negative breast cancer (TNBC), sponsored by Fudan University. Started Mar 2016; status: completed.
02
Drugs
paclitaxel
03
Conditions
triple-negative breast cancer (TNBC)
Beyond the preview
Go deeper on NCT02546934.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02546934.